- 1、本文档共16页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Patients with advanced non-small cell lung cancer clinical coagulation of
PAGE \* MERGEFORMAT 16
Patients with advanced non-small cell lung cancer clinical coagulation of
Of: Yangguo Wang, Fu Qi, Xu Yongmei, Gao Shan, Zhang Qing, Zhao Wenshuo, Wang Xiaomin
[Abstract] Objective advanced non-small cell lung cancer (NSCLC) and the distribution of blood coagulation indices and patient prognosis, and long-term syndromes associated thrombotic events. Methods hospitalized patients with NSCLC were studied retrospectively, their coagulation application software for data analysis SPSS13.0. Results of non-advanced group 1 patients and a more abnormal coagulation were 10 cases (38.5%) and 8 patients (30.8%), while the advanced group of NSCLC patients were 95 cases (71.4%) and 77 patients (57.9%), statistically significant difference between the groups (P lt;0.05), plasma fibrinogen (FIB), D-dimer (D-dimer) levels in the late group and non-advanced group of patients was significantly different. coagulation of FIB and D-dimer values #8203;#8203;in patients with advanced NSCLC survival were negatively correlated (P lt;0.05). Closely related to the level of gas deficiency FIB (P lt;0.05). Blood stasis, qi stagnation and blood clotting status closely, but only the former was statistically significant (P lt;0.05). Late group the incidence of thrombotic adverse events than non- late treatment groups. Conclusion prevalent in patients with advanced NSCLC coagulopathy, and with poor prognosis, the initial prompt Yiqihuoxue Chinese medicine can be used as the abnormal state of coagulation in the direction of effective interventions.
[Keywords:] non-small cell lung cancer, coagulation, thrombotic events, TCM
Abstract: Objective To discuss the distribution of coagulation markers in patients with advanced non-small cell lung cancer (NSCLC) and the correlation of these markers with the prognosis of the patients, the TCM syndrome and the long-term thrombotic events. Method Hospitalized NSCLC patients were selected for retrospective investigation
您可能关注的文档
- Part of the routine biochemical testing by the project time and position of blood.doc
- Partial methyl quality topical treatment with the economic times of refreshing may be embedded in a paronychia of the clinical observation.doc
- Partial brake on insulin sensitivity in aged rats.doc
- Partial least-squares method in TCM liver cirrhosis classification modeling.doc
- Part- knowledge before selecting rule.doc
- Partial puncture trocar vestibular gland cyst (abscess) swollen 30 cases of.doc
- Partial splenic embolization adverse clinical observation and nursing.doc
- Partial splenic embolization for hypersplenism Research_0.doc
- Partial splenic artery embolization for hypersplenism clinical observation.doc
- Partial splenic embolization for hypersplenism Research.doc
- Patients with advanced non-small cell lung cancer clinical coagulation of_0.doc
- Patients with acute myocardial infarctiongranulocyte macrophage colony-stimulating factor in blood CD34 cells and changes in inflammatory factors.doc
- Patients with atrial fibrillation sarcoplasmic reticulum RyR2 receptor mRNA expression of.doc
- Patients with acute tetramine poisoning First aid and nursing_0.doc
- Patients with autoimmune thyroiditis TSH thyroid autoantibodies and thyroid cells associated pathological changes.doc
- Patients with amyotrophic lateral sclerosis Investigation Anxiety and Depression.doc
- Patients with benign prostatic hyperplasia by transurethral resection of prostate of 17 patients.doc
- Patients with advanced non-small cell lung cancer Clinical analysis of coagulation.doc
- Patients with advanced ovarian cancer nursing intervention therapy.doc
- Patients with benign prostatic hyperplasia clinical characteristics of metabolic syndrome.doc
文档评论(0)